ArticleEuropean heart journal. Digital health2025
The 'Advancing Cardiovascular Risk Identification with Structured Clinical Documentation and Biosignal Derived Phenotypes Synthesis' project: conceptual design, project planning, and first implementation experiences.
Article in European heart journal. Digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units.NPJ digital medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Personalized risk assessment tools (PRTs) are recommended by cardiovascular guidelines to tailor prevention, diagnosis, and treatment. However, PRT implementation in clinical routine is poor. ACRIBiS (Advancing Cardiovascular Risk Identification with Structured Clinical Documentation and Biosignal Derived Phenotypes Synthesis) aims to establish interoperable infrastructures for standardized documentation of routine data and integration of high-resolution biosignals (HRBs) enabling data-based risk assessment. Methods and results: Established cardiovascular risk scores were selected by their predictive performance and served as basis for building a core cardiovascular dataset with risk-relevant clinical routine information. Data items not yet represented in the Medical Informatics Inititative (MII) Core Dataset (CDS) FHIR profiles will be added to an extension module 'Cardiology' allowing for maximum interoperability. HRB integration will be implemented at each site through a modular infrastructure for electrocardiography (ECG) processing. Predictive performance of PRTs and their dynamic recalibration through HRB integration will be evaluated within the ACRIBiS cohort consisting of 5250 prospectively recruited patients at 15 German academic cardiology departments with 12-month follow-up. The potential of visualising these risks to improve patient education will also be assessed and supported by the development of a self-assessment app. Discussion: The ACRIBiS project presents an innovative concept to harmonize clinical data documentation and integrate ECG data, ultimately facilitating personalized risk assessment to improve patient empowerment and prognosis. Importantly, the consensus-based documentation and interoperability specifications developed will support the standardisation of routine patient data collection at the national and international levels, while the ACRIBiS cohort dataset will be available for broad secondary use. Trial registration: The study is registered at the German study registry (DRKS): #DRKS00034792.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.